Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Massar Alsamraae"'
Autor:
Diane L. Costanzo-Garvey, Adam J. Case, Gabrielle F. Watson, Massar Alsamraae, Arpita Chatterjee, Rebecca E. Oberley-Deegan, Samikshan Dutta, Maher Y. Abdalla, Tammy Kielian, Merry L. Lindsey, Leah M. Cook
Publikováno v:
Clinical & Experimental Metastasis. 39:641-659
Bone metastatic prostate cancer (BM-PCa) remains one of the most difficult cancers to treat due to the complex interactions of cancer and stromal cells. We previously showed that bone marrow neutrophils elicit an anti-tumor immune response against BM
Autor:
Massar Alsamraae, Diane Costanzo-Garvey, Benjamin A. Teply, Shawna Boyle, Gary Sommerville, Zach Herbert, Colm Morrissey, Alicia J. Dafferner, Maher Y. Abdalla, Rachel W. Fallet, Tammy Kielian, Heather Jensen-Smith, Edson I. deOliveira, Keqiang Chen, Ian A. Bettencourt, Ji Ming Wang, Daniel W. McVicar, Tyler Keeley, Fang Yu, Leah M. Cook
Prostate Cancer (PCa) bone metastases are associated with spinal cord compression, fracture, bone pain and death. Despite advances in the medical therapy for localized disease, metastatic disease is incurable and osseous progression is largely dictat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73dfed41390edef0fe97acce33155bf0
https://doi.org/10.1101/2022.12.30.522329
https://doi.org/10.1101/2022.12.30.522329
Autor:
Leah M. Cook, Massar Alsamraae
Publikováno v:
Cancer and Metastasis Reviews. 40:413-425
Metastasis, especially bone metastasis, is a major cause of cancer-related deaths, which is associated with long-term pain due to skeletal-related events and poor quality of life. Tumor cells alter the bone microenvironment through aberrant activatio
Autor:
Catherine S. Johnson, Diane Costanzo-Garvey, Massar Alsamraae, Jeremy S. Frieling, Leah M. Cook
Publikováno v:
Cancer Research. 83:82-82
In 2022, the American Cancer Society estimates that over 34,000 men will die of PCa, largely due to metastatic PCa. Up to 90% of advanced prostate cancers metastasize to bone, and there are currently no curative therapies for bone metastatic prostate
Autor:
Diane L, Costanzo-Garvey, Adam J, Case, Gabrielle F, Watson, Massar, Alsamraae, Arpita, Chatterjee, Rebecca E, Oberley-Deegan, Samikshan, Dutta, Maher Y, Abdalla, Tammy, Kielian, Merry L, Lindsey, Leah M, Cook
Publikováno v:
Clinicalexperimental metastasis. 39(4)
Bone metastatic prostate cancer (BM-PCa) remains one of the most difficult cancers to treat due to the complex interactions of cancer and stromal cells. We previously showed that bone marrow neutrophils elicit an anti-tumor immune response against BM
Autor:
Tammy Kielian, Adam J. Case, Leah M. Cook, Yangsheng Yu, Massar Alsamraae, Cortney E. Heim, Tyler Keeley, Diane L. Costanzo-Garvey, Jeremy S. Frieling, Kaihong Su, Gabrielle F. Watson, Colm Morrissey
Publikováno v:
Cancer Immunology, Immunotherapy
Bone metastatic prostate cancer (BM-PCa) significantly reduces overall patient survival and is currently incurable. Current standard immunotherapy showed promising results for PCa patients with metastatic, but less advanced, disease (i.e., fewer than